News | August 01, 2023
Concord Biotech’s IPO to open on 4th August, 2023
The company through its IPO will fetch Rs 1475.26 crore - Rs 1550.59 crore at the lower and upper end of the price band.
The company through its IPO will fetch Rs 1475.26 crore - Rs 1550.59 crore at the lower and upper end of the price band.
Jemperli is the only immuno-oncology treatment approved in the frontline setting for this patient population in combination with chemotherapy
Contracts are related to a $487 million biotech expansion project in Denmark and first phase of a new life sciences production facility valued at $574 million in Central U.S.
Unfortunate to see PM’s ‘Make in India’ dream being bulldozed
Uses a simple mechanical approach for removing intrauterine tissues
The approved product has an estimated market size of around US$ 210 million for the twelve months ending May 2023
Teva will leverage Honeywell’s ‘Energy as a Service’ (EaaS) model
Through the use of robotic assisted orthopaedic surgeries, the success rate is close to 98%
Apollo Transplant program is the first program in India to cross the landmark of 18500 kidney transplants, 4300 liver transplants and 500 pediatric liver transplants
The agency issued a Form 483 with 6 observations for Drug Substance, Drug Product units and Quality Control laboratories
Subscribe To Our Newsletter & Stay Updated
